I wrote a blog article a couple of years ago about how there is a lot of misinformation given out by many websites where patients can write in and ask questions related to breast pathology issues.
Unfortunately, in the past few years nothing seems to have changed. There are still many sites out there where [...]

Question: Pathologist gave a diagnosis of Invasive ductal cancer grade 1 (2/2/1), however when asked said it was a tubular cancer are these two different? thank you

Question: What is the difference between invasive lobular and ductal carcinoma? My first biopsy I had at my ultrasound said “invasive lobular carcinoma grade 2/3″ and my surgery biopsy said “invasive ductal carcinoma grade 2/3″. Does this make any difference?

Question: My core biopsy path report stated a tumor grade of 1. Four weeks later, the lumpectomy path report states tumor grade 3. Can the tumor really be progressing this rapidly? Thanks for your time.

Question: What is “sclerosing adenosis”? Is this related to breast cancer? That’s my diagnosis on my biopsy that my doctor did. Do I need to have surgery? She said no, but I’m concerned. It sounds worrisome.

Question: My core biopsy came back as “fibrocystic changes with a small focus of atypical ductal hyperplasia. calcifications are present within the focus of atypical ductal hyperplasia and in surrounding ducts.” My sister’s friend is a breast cancer nurse and recommended I get a second opinion at her hospital and so I had them [...]

Question: Hi, two weeks ago I had a mammogram that showed calcium in my left breast that was new according to my doctor. They also saw something else on the mammogram with the calcium and then I had an ultrasound. They told me I had a small mass near my nipple that had calcium [...]

Question: I am 56 years old and I go for my mammogram every year and my doctor said there were some calcificatons in my right breast and recommends biopsy. So I had a needle biopsy that showed “lobular carcinoma in situ” that is what the report said. He said I needed surgery which I dont [...]

A recent news release from Genomic Health, Inc. indicates preliminary data shows that the Oncotype DX® test can provide a score predicting risk of local recurrence in patients with a diagnosis of ductal carcinoma in situ (DCIS).
DCIS is a very heterogeneous disease and there is disagreement in the breast care community as to how to [...]

I recently posted a pdf version of our course on “Controversies on the Management of High Risk Breast Lesions on Core Biopsy” that my Radiology colleague and I gave in San Diego last year.  The diagnoses we are referring to as “high risk” on core biopsy include atypical lobular hyperplasia/lobular carcinoma in situ, papilloma, radial [...]